OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients
Sixten Körper, Beate Grüner, Daniel Zickler, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 24
Open Access | Times Cited: 20
Sixten Körper, Beate Grüner, Daniel Zickler, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 24
Open Access | Times Cited: 20
Showing 20 citing articles:
Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 5, pp. 381-395
Closed Access | Times Cited: 25
Early antibody treatment, inflammation, and risk of post-COVID conditions
Kelly A. Gebo, Sonya L. Heath, Yuriko Fukuta, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 15
Kelly A. Gebo, Sonya L. Heath, Yuriko Fukuta, et al.
mBio (2023) Vol. 14, Iss. 5
Open Access | Times Cited: 15
Treatable traits for long COVID
Hayley Lewthwaite, Anthony Byrne, Bruce J. Brew, et al.
Respirology (2023) Vol. 28, Iss. 11, pp. 1005-1022
Open Access | Times Cited: 14
Hayley Lewthwaite, Anthony Byrne, Bruce J. Brew, et al.
Respirology (2023) Vol. 28, Iss. 11, pp. 1005-1022
Open Access | Times Cited: 14
SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against Omicron subvariants BA.1, BA.2 and BA.5 and can be predicted by anti-S antibody concentrations in serological assays
Alina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Alina Seidel, Simone Hoffmann, Bernd Jahrsdörfer, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Immune Plasma for the Treatment of COVID-19: Lessons Learned so far
Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, et al.
Hämostaseologie (2023) Vol. 43, Iss. 01, pp. 067-074
Open Access | Times Cited: 5
Hubert Schrezenmeier, Simone Hoffmann, Henrike Hofmann, et al.
Hämostaseologie (2023) Vol. 43, Iss. 01, pp. 067-074
Open Access | Times Cited: 5
Short- and long-term effects of imatinib in hospitalized COVID-19 patients: A randomized trial
Alex L.E. Halme, Sanna Laakkonen, Jarno Rutanen, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106217-106217
Closed Access | Times Cited: 1
Alex L.E. Halme, Sanna Laakkonen, Jarno Rutanen, et al.
Journal of Infection (2024) Vol. 89, Iss. 3, pp. 106217-106217
Closed Access | Times Cited: 1
Early Treatment, Inflammation and Post-COVID Conditions
Kelly A. Gebo, Sonya L. Heath, Yuriko Fukuta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Kelly A. Gebo, Sonya L. Heath, Yuriko Fukuta, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
High‐titer post‐vaccine COVID‐19 convalescent plasma for immunocompromised patients during the first omicron surge
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Ralph Tayyar, Lisa Wong, Alex Dahlen, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 2
Open Access | Times Cited: 3
Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19 (COVIC-19): protocol for a randomised, open-label trial
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, et al.
BMJ Open (2023) Vol. 13, Iss. 4, pp. e071277-e071277
Open Access | Times Cited: 3
Maxime Desmarets, Simone Hoffmann, Charline Vauchy, et al.
BMJ Open (2023) Vol. 13, Iss. 4, pp. e071277-e071277
Open Access | Times Cited: 3
Correlation between Clinical Characteristics and Antibody Levels in COVID-19 Convalescent Plasma Donor Candidates
Günalp Uzun, Rebecca Müller, Karina Althaus, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1357-1357
Open Access | Times Cited: 2
Günalp Uzun, Rebecca Müller, Karina Althaus, et al.
Viruses (2023) Vol. 15, Iss. 6, pp. 1357-1357
Open Access | Times Cited: 2
Short- and long-term effects of imatinib in patients hospitalised for COVID-19 infection: A randomised controlled trial
Alex L.E. Halme, Sanna Laakkonen, Jarno Rutanen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Alex L.E. Halme, Sanna Laakkonen, Jarno Rutanen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Zum Stellenwert von Rekonvaleszentenplasma bei der Therapie von COVID-19
Sixten Körper, Erhard Seifried, Hubert Schrezenmeier
DMW - Deutsche Medizinische Wochenschrift (2023) Vol. 148, Iss. 07, pp. 423-426
Closed Access | Times Cited: 1
Sixten Körper, Erhard Seifried, Hubert Schrezenmeier
DMW - Deutsche Medizinische Wochenschrift (2023) Vol. 148, Iss. 07, pp. 423-426
Closed Access | Times Cited: 1
Too Early to Abandon Convalescent Plasma for Supportive Treatment of COVID-19
Rainer Seitz, Lutz Gürtler, Ute Vahlensieck, et al.
Transfusion Medicine and Hemotherapy (2023) Vol. 50, Iss. 3, pp. 256-258
Open Access | Times Cited: 1
Rainer Seitz, Lutz Gürtler, Ute Vahlensieck, et al.
Transfusion Medicine and Hemotherapy (2023) Vol. 50, Iss. 3, pp. 256-258
Open Access | Times Cited: 1
Covid-19 : encore une place pour le plasma de convalescent ? Focus sur les patients immunodéprimés
Quentin Richier, Thomas Hueso, Pierre Tiberghien, et al.
La Revue de Médecine Interne (2023) Vol. 44, Iss. 9, pp. 467-471
Open Access | Times Cited: 1
Quentin Richier, Thomas Hueso, Pierre Tiberghien, et al.
La Revue de Médecine Interne (2023) Vol. 44, Iss. 9, pp. 467-471
Open Access | Times Cited: 1
Hyperimmunplasma: Gewinnung, Verarbeitung und therapeutische Anwendungen
Gabriele Niemann, Matthias Germer, Matthias Hauf, et al.
Transfusionsmedizin (2023) Vol. 13, Iss. 01, pp. 18-29
Closed Access
Gabriele Niemann, Matthias Germer, Matthias Hauf, et al.
Transfusionsmedizin (2023) Vol. 13, Iss. 01, pp. 18-29
Closed Access
Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection
Cansu Hemşinlioğlu, Nil Banu Pelit, Ömür Selin Günaydın, et al.
Research Square (Research Square) (2023)
Open Access
Cansu Hemşinlioğlu, Nil Banu Pelit, Ömür Selin Günaydın, et al.
Research Square (Research Square) (2023)
Open Access
Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection
Cansu Hemşinlioğlu, Nil Banu Pelit, Ömür Selin Günaydın, et al.
Research Square (Research Square) (2023)
Open Access
Cansu Hemşinlioğlu, Nil Banu Pelit, Ömür Selin Günaydın, et al.
Research Square (Research Square) (2023)
Open Access
Längerfristiger Nutzen von COVID-19-Rekonvaleszentenplasma
Transfusionsmedizin (2023) Vol. 13, Iss. 02, pp. 73-73
Closed Access
Transfusionsmedizin (2023) Vol. 13, Iss. 02, pp. 73-73
Closed Access
Längerfristiger Nutzen von COVID-19-Rekonvaleszentenplasma
Journal Club AINS (2023) Vol. 12, Iss. 02, pp. 84-86
Closed Access
Journal Club AINS (2023) Vol. 12, Iss. 02, pp. 84-86
Closed Access
Effectiveness of ACB-IP 1.0 Universal Pathogen Free Concentrated Cocktail Convalescent Plasma in COVID-19 Infection
Cansu Hemşinlioğlu, Nil Banu Pelit, Koray Yalçın, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
Cansu Hemşinlioğlu, Nil Banu Pelit, Koray Yalçın, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 1
